Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Masked, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ402 in Participants With Diabetic Macular Edema (DME)

NCT05712720 is registered in ClinicalTrials.gov with Rezolute as lead sponsor.

NCT NCT05712720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05712720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Masked, Placebo-Controlled, Parallel-Arm Study to Evaluate the Efficacy and Safety of RZ402 in Participants With Diabetic Macular Edema (DME)
Lead sponsor
Rezolute
Phase
Phase 2
Overall status
Completed
Start date
February 6, 2023
Completion date
April 11, 2024
Enrollment
94 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema